We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · December 17, 2020

Short DAPT Followed by P2Y12 Inhibitor Monotherapy vs Prolonged DAPT After PCI With Second-Generation Drug-Eluting Stents

European Heart Journal


Additional Info

European Heart Journal
Short Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy vs. Prolonged Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Eur Heart J 2020 Dec 07;[EPub Ahead of Print], D Giacoppo, Y Matsuda, LN Fovino, G D'Amico, G Gargiulo, RA Byrne, D Capodanno, M Valgimigli, R Mehran, G Tarantini

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading